Clinical Trial Update: Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm in Traumatic Subarachnoid Hemorrhage [EARLY_Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating intravenous magnesium sulfate to reduce cerebral vasospasm after traumatic subarachnoid hemorrhage; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Subarachnoid Hemorrhage

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Assiut University | Conditions: Trauma and Emergency Care | EARLY_Phase 1 | Status: NOT_YET_RECRUITING